- Conditions
- Endometriosis
- Interventions
- Cabergoline, Norethindrone acetate
- Drug
- Lead sponsor
- Boston Children's Hospital
- Other
- Eligibility
- 15 Years to 40 Years · Female only
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–5
of 5
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Endometriosis
- Interventions
- Cabergoline 0.5 MG, Placebo - Cap
- Drug
- Lead sponsor
- Boston Children's Hospital
- Other
- Eligibility
- 15 Years to 40 Years · Female only
- Enrollment
- 129 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2026
- U.S. locations
- 6
- States / cities
- Palo Alto, California • Aurora, Colorado • Boston, Massachusetts + 1 more
- Conditions
- Infertility, Female
- Interventions
- Cabergoline Pill
- Drug
- Lead sponsor
- Fertility Center of Las Vegas
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 70 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2021
- U.S. locations
- 1
- States / cities
- Las Vegas, Nevada
- Conditions
- Cocaine-Related Disorders, Substance-Related Disorders
- Interventions
- Cabergoline, Placebo
- Drug
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- NIH
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 140 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2001 – 2004
- U.S. locations
- 2
- States / cities
- Torrance, California • Charleston, South Carolina
- Conditions
- Body Weight, Impaired Glucose Tolerance in Obese
- Interventions
- Cabergoline, placebo
- Drug · Other
- Lead sponsor
- Columbia University
- Other
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2002 – 2011
- U.S. locations
- 1
- States / cities
- New York, New York